The present invention relates to Multifunctional FAO-OXPHOS complex inhibitor for use in the treatment of high mitochondrial respiration (OX+) cancers. Advantageously, it has been discovered that inhibition of the mitochondrial trifunctional protein (MTP) altered high mitochondrial respiration (OX+) tumor...